Possible Role of VEGF in the Progression of Kidney Disease in Streptozotocin (STZ)-induced Diabetic Rats: Effects of an ACE Inhibitor and an Angiotensin II Receptor Antagonist

Progression Of Kidney Disease

ACE Inhibitor or Angiotensin II Receptor Antagonist Attenuates Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats

Diabetes ◽

10.2337/diabetes.55.02.06.db05-0885 ◽

2006 ◽

Vol 55 (2) ◽

pp. 341-348 ◽

Cited By ~ 76

Author(s):

L. J. Coppey ◽

E. P. Davidson ◽

T. W. Rinehart ◽

J. S. Gellett ◽

C. L. Oltman ◽

...

Keyword(s):

Angiotensin Ii ◽

Diabetic Neuropathy ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

Diabetic Rats ◽

Angiotensin Ii Receptor ◽

Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake

Journal of Hypertension ◽

10.1097/00004872-200111000-00021 ◽

2001 ◽

Vol 19 (11) ◽

pp. 2087-2095 ◽

Cited By ~ 38

Author(s):

Cory D. Griffiths ◽

Trefor O. Morgan ◽

Leanne M. D. Delbridge

Keyword(s):

Angiotensin Ii ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

Angiotensin Ii Receptor ◽

Combined Administration

Additive Antiproteinuric Effect of Combination Therapy with ACE Inhibitor and Angiotensin II Receptor Antagonist: Differential Short-term Response between IgA Nephropathy and Diabetic Nephropathy

Yonsei Medical Journal ◽

10.3349/ymj.2003.44.3.463 ◽

2003 ◽

Vol 44 (3) ◽

pp. 463 ◽

Cited By ~ 17

Author(s):

Moon Jae Kim ◽

Joon Ho Song ◽

Ju Hyun Suh ◽

Seoung Woo Lee ◽

Gyoung A Kim

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Combination Therapy ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

Angiotensin Ii Receptor ◽

Short Term ◽

Antiproteinuric Effect ◽

Term Response

Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease

Clinical and Experimental Hypertension ◽

10.3109/10641963.2010.503299 ◽

2011 ◽

Vol 33 (6) ◽

pp. 366-372 ◽

Cited By ~ 8

Author(s):

Toshihiko Ishimitsu ◽

Eri Ohno ◽

Nobuyuki Nakano ◽

Satoshi Furukata ◽

Akira Akashiba ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Antihypertensive Therapy ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

Clinical and Experimental Nephrology ◽

10.1007/s10157-003-0241-3 ◽

2003 ◽

Vol 7 (3) ◽

pp. 221-230 ◽

Cited By ~ 13

Author(s):

Yasuhiko Iino ◽

Matsuhiko Hayashi ◽

Tetsuya Kawamura ◽

Tatsuo Shiigai ◽

Yasuhiko Tomino ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

Renal Protection ◽

Hypertensive Patients

EFFECTS OF TREATMENT WITH ACE-INHIBITOR AT HIGH DOSE OR ANGIOTENSIN II RECEPTOR ANTAGONIST ON ARTERIAL DISTENSIBILITY IN HEART FAILURE

Journal of Hypertension ◽

10.1097/00004872-200006001-00269 ◽

2000 ◽

Vol 18 ◽

pp. S82

Author(s):

C. Giannattasio ◽

M. Failla ◽

F. Achilli ◽

A. Vincenzi ◽

A. Grappiolo ◽

...

Keyword(s):

Heart Failure ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

High Dose ◽

Angiotensin Ii Receptor ◽

Arterial Distensibility

ACE inhibitor-associated angioedema does not appear to be a contraindication to angiotensin II receptor antagonist therapy,

Inpharma Weekly ◽

10.2165/00128413-200414410-00040 ◽

2004 ◽

Vol &NA; (1441) ◽

pp. 16

Author(s):

&NA;

Keyword(s):

Angiotensin Ii ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

Angiotensin Ii Receptor ◽

Antagonist Therapy

Addition of Angiotensin II Receptor Antagonist to an ACE Inhibitor in Heart Failure Improves Cardiovascular Function by a Bradykinin-Mediated Mechanism

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-200304000-00017 ◽

2003 ◽

Vol 41 (4) ◽

pp. 632-639 ◽

Cited By ~ 10

Author(s):

Takafumi Koji ◽

Katsuya Onishi ◽

Kaoru Dohi ◽

Ryuji Okamoto ◽

Masaki Tanabe ◽

...

Keyword(s):

Heart Failure ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

Cardiovascular Function ◽

Angiotensin Ii Receptor ◽

ACE inhibitor-associated angioedema does not appear to be a contraindication to angiotensin II receptor antagonist therapy,

Reactions Weekly ◽

10.2165/00128415-200410050-00013 ◽

2004 ◽

Vol &NA; (1005) ◽

pp. 5

Author(s):

&NA;

Keyword(s):

Angiotensin Ii ◽

Receptor Antagonist ◽

Ace Inhibitor ◽

Angiotensin Ii Receptor ◽

Antagonist Therapy

Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease

European Journal of Pediatrics ◽

10.1007/s004310000495 ◽

2000 ◽

Vol 159 (8) ◽

pp. 590-593 ◽

Cited By ~ 20

Author(s):

Rodo O. von Vigier ◽

Priska M. Zberg ◽

Oliver Teuffel ◽

Mario G. Bianchetti

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Receptor Antagonist ◽

Angiotensin Ii Receptor ◽